Abstract

1781P Health-related quality of life (HRQoL) deterioration-free survival (DetFS) by prostate-specific antigen (PSA) decline in darolutamide (DARO)-treated patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) from ARAMIS

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Nadir Prostate-specific Antigen as an Independent Predictor of Survival Outcomes: A Post Hoc Analysis of the PROSPER Randomized Clinical Trial.
Maha Hussain ... Bettina Noerby
Investigative urology | VOL. 209
Maha Hussain, et. al.Maha Hussain ... Bettina Noerby
01 Mar 2023
633P Tolerability and treatment response to darolutamide (DARO) in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) in the phase III ARAMIS trial
K Fizazi ... I Kuss
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 31
K Fizazi, et. al.K Fizazi ... I Kuss
01 Sep 2020
Post Hoc Analysis of Rapid and Deep Prostate-specific Antigen Decline and Patient-reported Health-related Quality of Life in SPARTAN and TITAN Patients with Advanced Prostate Cancer
Eric J Small ... Neeraj Agarwal
European Urology Oncology | VOL. -
Eric J Small, et. al.Eric J Small ... Neeraj Agarwal
01 Dec 2023
Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: an analysis of the SPARTAN randomised, placebo-controlled, phase 3 trial.
Fred Saad ... Kelly Mcquarrie
Lancet Oncology | VOL. 19
Fred Saad, et. al.Fred Saad ... Kelly Mcquarrie
10 Sep 2018
View more papers

More From: Annals of oncology : official journal of the European Society for Medical Oncology

Paper Title
Journal
Date
Author
Neratinib and ado-trastuzumab emtansine for pretreated and untreated human epidermal growth factor receptor 2 (HER2)-positive breast cancer brain metastases: Translational Breast Cancer Research Consortium trial 022
R.A Freedman ... N.U Lin
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
R.A Freedman, et. al.R.A Freedman ... N.U Lin
06 Jul 2024
Primary tumor resection for asymptomatic colorectal cancer with unresectable metastasis: the end of the dilemma
Sebastiano Biondo ... Esther Kreisler
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
Sebastiano Biondo, et. al.Sebastiano Biondo ... Esther Kreisler
03 Jul 2024
Challenging immune exhaustion in early recurrent triple-negative breast cancer: pitfalls and hopes
P Tarantino ... S M Tolaney
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
P Tarantino, et. al.P Tarantino ... S M Tolaney
01 Jul 2024
Elevating Cancer on the Global Health Agenda: Towards the 4th High-Level Meeting on NCDs 2025
Raffaella Casolino ... Andrè Ilbawi
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
Raffaella Casolino, et. al.Raffaella Casolino ... Andrè Ilbawi
01 Jul 2024
View more papers